Logo image of VAQC

VECTOR ACQUISITION CORP II-A (VAQC) Stock Fundamental Analysis

NASDAQ:VAQC - Nasdaq - KYG9460A1040 - Common Stock - Currency: USD

10.67  0 (0%)

Fundamental Rating

1

Taking everything into account, VAQC scores 1 out of 10 in our fundamental rating. VAQC was compared to 0 industry peers in the Unkown industry. VAQC may be in some trouble as it scores bad on both profitability and health. VAQC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

VAQC had positive earnings in the past year.
VAQC had a negative operating cash flow in the past year.
VAQC Yearly Net Income VS EBIT VS OCF VS FCFVAQC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 2M 4M

1.2 Ratios

Industry RankSector Rank
ROA 17.48%
ROE 30.08%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VAQC Yearly ROA, ROE, ROICVAQC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 0.5 1

1.3 Margins

VAQC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VAQC Yearly Profit, Operating, Gross MarginsVAQC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

2

2. Health

2.1 Basic Checks

VAQC has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for VAQC is higher compared to a year ago.
VAQC Yearly Shares OutstandingVAQC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M 40M 50M
VAQC Yearly Total Debt VS Total AssetsVAQC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.31 indicates that VAQC is not in any danger for bankruptcy at the moment.
VAQC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 5.31
ROIC/WACCN/A
WACCN/A
VAQC Yearly LT Debt VS Equity VS FCFVAQC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.13 indicates that VAQC may have some problems paying its short term obligations.
A Quick Ratio of 0.13 indicates that VAQC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
VAQC Yearly Current Assets VS Current LiabilitesVAQC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 100K 200K 300K 400K 500K

1

3. Growth

3.1 Past

VAQC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 833.33%, which is quite impressive.
EPS 1Y (TTM)833.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.11, which means the current valuation is very expensive for VAQC.
VAQC is valuated rather expensively when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.11
Fwd PE N/A
VAQC Price Earnings VS Forward Price EarningsVAQC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VAQC Per share dataVAQC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VAQC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VECTOR ACQUISITION CORP II-A

NASDAQ:VAQC (3/4/2024, 8:25:30 PM)

10.67

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change0%
Ins Owners0.46%
Ins Owner Change0%
Market Cap173.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.11
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.23
P/tB 7.23
EV/EBITDA N/A
EPS(TTM)0.28
EY2.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.48
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.48%
ROE 30.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 5.31
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)833.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.16%
OCF growth 3YN/A
OCF growth 5YN/A